tradingkey.logo
tradingkey.logo
Buscar

Bio Rad Laboratories Inc

BIO
Añadir a la lista de seguimiento
293.050USD
-2.250-0.76%
Horarios del mercado ETCotizaciones retrasadas 15 min
7.86BCap. mercado
48.60P/E TTM

Más Datos de Bio Rad Laboratories Inc Compañía

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Información de Bio Rad Laboratories Inc

Símbolo de cotizaciónBIO
Nombre de la empresaBio Rad Laboratories Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoSchwartz (Norman D)
Número de empleados7700
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección1000 Alfred Nobel Dr
CiudadHERCULES
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal94547
Teléfono15107247000
Sitio Webhttps://www.bio-rad.com/
Símbolo de cotizaciónBIO
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoSchwartz (Norman D)

Ejecutivos de Bio Rad Laboratories Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
715.00
+56.92%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
715.00
+56.92%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
346.00
-158.96%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
308.00
--
Rajat Mehta
Rajat Mehta
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
58.00
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
715.00
+56.92%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Bio Rad Laboratories Inc?

Los cinco principales accionistas de Bio Rad Laboratories Inc son: Mr. Norman D. Schwartz

¿Cuántas instituciones poseen acciones de Bio Rad Laboratories Inc (BIO)?

A fecha de 2026Q1, 1041 instituciones poseen acciones de Bio Rad Laboratories Inc, con un valor de mercado combinado de aproximadamente 18.42M, lo que representa el 84.86% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4188613.00.
KeyAI